ArticleMetabolomics : Official journal of the Metabolomic Society2026
Serum and urine metabolomic profiling in Miniature Schnauzer dogs with and without calcium oxalate urolithiasis.
Article in Metabolomics : Official journal of the Metabolomic Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
introductionCalcium oxalate (CaOx) urolithiasis is associated with metabolic disorders, including dyslipidemia. Improved understanding of underlying metabolic derangements is needed. The Miniature Schnauzer presents an opportunity to investigate connections between hyperlipidemia and CaOx stones, as both are prevalent in the breed.
objectivesTo characterize lipidomic (serum) and metabolomic (serum and urine) profiles in Miniature Schnauzers with (cases) and without (controls) CaOx urolithiasis.
methodsUltrahigh performance liquid chromatography-tandem mass spectroscopy was performed on serum from cases (n = 15) and controls (n = 27) for lipidomic and metabolomic analysis. Urine metabolomics was included for a subset of dogs. Ten metabolites with previously established biological links to urolithiasis were prespecified as "high priority." Cases and controls were compared to identify differentially abundant metabolites (FDR-adjusted q-values).
resultsNo lipid species were differentially abundant. Three serum metabolites differed between groups (all lower in cases): 10-undecenoate, N-delta-acetylornithine, and glutarate (q-values 0.005, 0.03, and 0.009, respectively). Cluster analysis of high priority metabolites identified a subset of cases with distinct profiles, characterized by lower citrate and higher phosphate, glycine, and hippurate. Urinary profiles exhibited 202 differentially abundant metabolites, including higher acetylcarnitine and carnitine in cases (q-values 0.002 for both).
conclusionsNo differences in lipids were identified between Miniature Schnauzers with and without CaOx stones. Distinct metabolic subsets of stone formers might exist within the breed. Reduced N-delta-acetylornithine in stone formers is also reported in human stone formers and might reflect dietary acid load. Acetylcarnitine and carnitine enrichment in the urine of stone formers also warrants further exploration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.